G. Aubert

Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting

G. Vassal, P. Couvreur, I. Brigger, 2002, Journal of Pharmacology and Experimental Therapeutics.

Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model.

G. Vassal, P. Couvreur, M. Appel, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

P. Opolon, B. Geoerger, G. Vassal, 2003, British Journal of Cancer.

Oncolytic Activity of the E 1 B-55 kDa-deleted Adenovirus ONYX-015 Is Independent of Cellular p 53 Status in Human Malignant Glioma Xenografts 1

P. Opolon, B. Geoerger, G. Vassal, 2002 .

Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.

P. Opolon, B. Geoerger, G. Vassal, 2002, Cancer research.

In vivo treatment with CPT-11 leads to differentiation of neuroblastoma xenografts and topoisomerase I alterations.

G. Vassal, A. Larsen, J. Morizet, 2004, Cancer research.

High level of stabilized angiostatin mediated by adenovirus delivery does not impair the growth of human neuroblastoma xenografts

P. Opolon, M. Perricaudet, G. Vassal, 2003, Cancer Gene Therapy.

No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan

P. Opolon, J. Schellens, G. Vassal, 2004, British Journal of Cancer.

In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts

Jacques Grill, Gilles Vassal, C. Sainte-Rose, 2003, Cancer Chemotherapy and Pharmacology.